Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)

Autor: Wouter P. Kluijfhout, Madeleine L. Drent, Alberto M. Pereira, Wouter W. de Herder, Ad R. M. M. Hermus, Gerlof D. Valk, Carolina R. C. Pieterman, Anouk N A van der Horst-Schrivers, Peter H. Bisschop, Olaf M. Dekkers, Joanne M. de Laat, Bas Havekes
Přispěvatelé: Guided Treatment in Optimal Selected Cancer Patients (GUTS), AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, AMS - Amsterdam Movement Sciences, Endocrinology, Internal medicine, Other Research, Interne Geneeskunde, RS: NUTRIM - R1 - Metabolic Syndrome, Internal Medicine
Rok vydání: 2015
Předmět:
Male
endocrine system diseases
Endocrinology
Diabetes and Metabolism

Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
Clinical Biochemistry
BELGIUM
Pituitary neoplasm
Biochemistry
DISEASE
Endocrinology
Non-U.S. Gov't
Multiple endocrine neoplasia
INCIDENTALOMAS
Netherlands
education.field_of_study
CLINICAL-PRACTICE GUIDELINE
Research Support
Non-U.S. Gov't

Middle Aged
PREVALENCE
MULTIPLE ENDOCRINE NEOPLASIA
Disease Progression
Female
medicine.symptom
Cohort study
Adenoma
Adult
medicine.medical_specialty
Adolescent
Population
Context (language use)
Research Support
DIAGNOSIS
Asymptomatic
TYPE-1 MEN1
Young Adult
Internal medicine
ADENOMAS
medicine
Multiple Endocrine Neoplasia Type 1
Journal Article
Humans
Pituitary Neoplasms
Prolactinoma
education
business.industry
Biochemistry (medical)
Pituitary tumors
medicine.disease
business
Follow-Up Studies
Zdroj: Journal of Clinical Endocrinology and Metabolism, 100(9), 3288-3296. ENDOCRINE SOC
Journal of clinical endocrinology and metabolism, 100(9), 3288-3296. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(9), 3288. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(9), 3288-3296. The Endocrine Society
Journal of Clinical Endocrinology & Metabolism, 100(9), 3288-3296. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 100, 3288-96
Journal of Clinical Endocrinology and Metabolism, 100(9), 3288-3296. Endocrine Society
de Laat, J M, Dekkers, O M, Pieterman, C R C, Kluijfhout, W P, Hermus, A R, Pereira, A M, van der Horst-Schrivers, A N, Drent, M L, Bisschop, P H, Havekes, B, de Herder, W W & Valk, G D 2015, ' Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG) ', Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 9, pp. 3288-3296 . https://doi.org/10.1210/JC.2015-2015
Journal of Clinical Endocrinology and Metabolism, 100, 9, pp. 3288-96
Journal of Clinical Endocrinology and Metabolism, 100(9), 3288-3296
ISSN: 1945-7197
0021-972X
Popis: Context: Guidelines advise lifelong radiological followup for asymptomatic pituitary adenomas (PITs) because of the risk for growth and subsequent visual field defects. In the context of multiple endocrine neoplasia type 1 (MEN 1) an even more comprehensive screening is advised because PITs are presumed to manifest more aggressive behavior. We studied the long-term course of MEN 1related PITs, which may be used as a model for sporadically occurring PITs.Objective: The aim of our study is to assess the results of systematic pre-symptomatic PIT screening and subsequent long-term followup of PITs with emphasis on nonfunctioning microadenomas diagnosed by screening.Patients and Methods: A cohort study was performed using the Dutch national MEN1 database, including greater than 90"/o of the Dutch MEN 1 population older than 16 years (n = 323).Main Outcome Measures: Screening results, natural course, and effects of treatment of PIT were assessed.Results: PIT was diagnosed in 123 patients with M EN 1 (38.1 %), of whom 66 were diagnosed by MEN 1-related screening. Ninety-one percent of the nonfunctioning PIT detected during screening (n = 35), did not require intervention during followup (median, 6.0 y). Three microadenomas showed limited growth but did not progress toward macroadenomas. Both screening-detected and prevalent prolactinomas (n = 52) responded well to treatment with dopamine agonists.Conclusion: Systematic presymptomatic screening for PIT in patients with MEN 1 predominantly results in detection of nonfunctioning microadenomas. Prolactinoma in patients with MEN1 responded well to medical treatment. Microadenomas grew only occasionally and after many years without clinical consequences. Frequent magnetic resonance imaging followup of nonfunctioning microadenomas in the context of MEN1 and sporadically occurring PITs therefore seems debatable.
Databáze: OpenAIRE